The miR-146b-3p/PAX8/NIS regulatory circuit modulates the differentiation phenotype and function of thyroid cells during carcinogenesis

Cancer Research

Volumn 75, Issue 19, 2015, Pages 4119-4130

  Riesco Eizaguirre, Garcilaso ^a,b,c   Wert Lamas, Leon ^a   Perales Paton, Javier ^a,d   Sastre Perona, Ana ^a   Fernandez, Lara P ^a   Santisteban, Pilar ^a  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c HOSPITAL DE MÓSTOLES   (Spain)

^d Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146B 3P; MICRORNA 146B 5P; SODIUM IODIDE SYMPORTER; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; COTRANSPORTER; IODIDE; MIRN146 MICRORNA, HUMAN; PAIRED BOX TRANSCRIPTION FACTOR; PAX8 PROTEIN, HUMAN; RNA; RNA, RECOMBINANT; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN TISSUE; NEXT GENERATION SEQUENCING; NIS GENE; NONHUMAN; ONCOGENE; PAX8 GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; THYROID CARCINOMA; THYROID CELL; ANTAGONISTS AND INHIBITORS; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; GENETICS; METABOLISM; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; THYROID GLAND; THYROID TUMOR; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BIOLOGICAL TRANSPORT; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; IODIDES; MICRORNAS; NEOPLASM PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; RNA; RNA INTERFERENCE; RNA, NEOPLASM; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS; TRANSFECTION;

EID: 84945425159     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3547     Document Type: Article

References (50)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
2. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-Term outcome of 444 patients with distantmetastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892-9.
3. Pasca diMaglianoM, Di Lauro R, Zannini M. Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci U S A 2000;97:13144-9.
4. Fernandez LP, Lopez-Marquez A, Santisteban P. Thyroid transcription factors in development, differentiation and disease. Nat Rev Endocrinol 2015;11:29-42.
5. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 1999;19:2051-60.
6. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-60.
7. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 2006;155:495-512.
8. Spitzweg C, Bible KC, Hofbauer LC, Morris JC. Advanced radioiodinerefractory differentiated thyroid cancer: The sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol 2014;2: 830-42.
9. Kozomara A, Griffiths-Jones S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014;42: D68-73.
10. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNAgenes in papillary thyroid carcinoma. ProcNatl Acad SciUS A 2005;102:19075-80.
11. Pallante P, Battista S, Pierantoni GM, Fusco A. Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 2014;10:88-101.
12. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A, et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007;25:1457-67.
13. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009;15:31-3.
14. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011;19:232-43.
15. Mullokandov G, Baccarini A, Ruzo A, Jayaprakash AD, Tung N, Israelow B, et al. High-Throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 2012;9:840-6.
16. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159:676-90.
17. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 2009;10:R25.
18. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-11.
19. Anders S, Pyl PT, Huber W. HTSeq-A Python framework to work with highthroughput sequencing data. Bioinformatics 2015;31:166-9.
20. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105.
21. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
22. Ruiz-Llorente S, Carrillo Santa de Pau E, Sastre-Perona A, Montero-Conde C, Gomez-Lopez G, Fagin JA, et al. Genome-wide analysis of Pax8 binding provides new insights into thyroid functions. BMC Genomics 2012; 13:147.
23. Sastre-Perona A, Santisteban P. Wnt-independent role of beta-catenin in thyroid cell proliferation and differentiation. Mol Endocrinol 2014;28: 681-95.
24. Zuckier LS, DohanO, Li Y, Chang CJ, Carrasco N, Dadachova E. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 2004;45:500-7.
25. De la Vieja A, Ginter CS, Carrasco N. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I symporter. Mol Endocrinol 2005;19:2847-58.
26. Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-40.
27. Robinson MD, Oshlack A. A scaling normalizationmethod for differential expression analysis of RNA-seq data. Genome Biol 2010;11:R25.
28. Young MD, Wakefield MJ, Smyth GK, Oshlack A. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol 2010;11:R14.
29. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 2010;95:5296-304.
30. Liang H, Li WH. MicroRNA regulation of human protein protein interaction network. RNA 2007;13:1402-8.
31. Budd WT, Weaver DE, Anderson J, Zehner ZE. microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes. Chem Biodivers 2012;9:857-67.
32. Martinez NJ, Ow MC, Barrasa MI, Hammell M, Sequerra R, Doucette-Stamm L, et al. A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity. Genes Dev 2008;22: 2535-49.
33. Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 2007;26:753-67.
34. Di Palma T, Conti A, de Cristofaro T, Scala S, Nitsch L, Zannini M. Identification of novel Pax8 targets in FRTL-5 thyroid cells by gene silencing and expression microarray analysis. PLoS ONE 2011;6:e25162.
35. Garcia B, Santisteban P. PI3K is involved in the IGF-I inhibition of TSHinduced sodium/iodide symporter gene expression. Mol Endocrinol 2002;16:342-52.
36. Costamagna E, Garcia B, Santisteban P. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene. J Biol Chem 2004;279:3439-46.
37. Lakshmanan A, Wojcicka A, Kotlarek M, Zhang X, Jazdzewski K, Jhiang S. microRNA-339-5p modulates Na+/I symporter-mediated radioiodide uptake. Endocr Relat Cancer 2015;22:11-21.
38. Huang CT, Oyang YJ, Huang HC, Juan HF. MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma. Sci Rep 2014;4:6495.
39. Swierniak M, Wojcicka A, Czetwertynska M, Stachlewska E, Maciag M, Wiechno W, et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J Clin Endocrinol Metab 2013;98:E1401-9.
40. Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I symporter (NIS): mechanism and medical impact. Endocr Rev 2014;35:106-49.
41. Leone V, D'Angelo D, Ferraro A, Pallante P, Rubio I, Santoro M, et al. A TSHCREB1-microRNA loop is required for thyroid cell growth. Mol Endocrinol 2011;25:1819-30.
42. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, et al. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 2009;69:8317-25.
43. Di Palma T, Filippone MG, Pierantoni GM, Fusco A, Soddu S, Zannini M. Pax8 has a critical role in epithelial cell survival and proliferation. Cell Death Dis 2013;4:e729.
44. Herranz H, Cohen SM. MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev 2010;24: 1339-44.
45. Shalgi R, Lieber D, Oren M, Pilpel Y. Global and local architecture of the mammalian microRNA-Transcription factor regulatory network. PLoS Comput Biol 2007;3:e131.
46. Martinez NJ, Walhout AJ. The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays 2009;31: 435-45.
47. Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 2013; 23:1383-9.
48. Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, et al. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab 2013;98: E196-205.
49. Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, et al. MicroRNA-222 andmicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013;119:4358-65.
50. Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer. Oncogene 2012;31:1910-22.